Metabolic Assessment of Gliomas Using 11C-Methionine, [18F] Fluorodeoxyglucose, and 11C-Choline Positron-Emission Tomography (original) (raw)

Abstract

BACKGROUND AND PURPOSE: Positron-emission tomography (PET) is a useful tool in oncology. The aim of this study was to assess the metabolic activity of gliomas using 11 C-methionine (MET), [ 18 F] fluorodeoxyglucose (FDG), and 11 C-choline (CHO) PET and to explore the correlation between the metabolic activity and histopathologic features.

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (34)

  1. Delbeke D, Meyerowitz C, Lapidus RL, et al. Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high- grade brain tumors with PET. Radiology 1995;195:47-52
  2. Derlon JM, Bourdet C, Bustany P, et al. [11c]l-Methionine uptake in gliomas. Neurosurgery 1989;25:720 -28
  3. Herholz K, Holzer T, Bauer B, et al. 11c-Methionine pet for differential diag- nosis of low-grade gliomas. Neurology 1998;50:1316 -22
  4. Kaschten B, Stevenaert A, Sadzot B, et al. Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine. J Nucl Med 1998;39:778 -85
  5. De Witte O, Goldberg I, Wikler D, et al. Positron emission tomography with injection of methionine as a prognostic factor in glioma. J Neurosurg 2001;95:746 -50
  6. Kim S, Chung JK, Im SH, et al. 11c-Methionine pet as a prognostic marker in patients with glioma: Comparison with 18f-FDG PET. Eur J Nucl Med Mol Imaging 2005;32:52-59
  7. Di Chiro G, DeLaPaz RL, Brooks RA, et al. Glucose utilization of cerebral gliomas measured by [18f] fluorodeoxyglucose and positron emission tomog- raphy. Neurology 1982;32:1323-29
  8. Ogawa T, Inugami A, Hatazawa J, et al. Clinical positron emission tomography for brain tumors: comparison of fludeoxyglucose f 18 and l-methyl-11c-me- thionine. AJNR Am J Neuroradiol 1996;17:345-53
  9. Tateishi U, Yamaguchi U, Seki K, et al. Glut-1 expression and enhanced glucose metabolism are associated with tumour grade in bone and soft tissue sarcomas: a prospective evaluation by [(18)f]fluorodeoxyglucose positron emission tomography. Eur J Nucl Med Mol Imaging 2006;33:683-91
  10. Buck A, Schirrmeister H, Kuhn T, et al. FDG uptake in breast cancer: Correla- tion with biological and clinical prognostic parameters. Eur J Nucl Med Mol Imaging 2002;29:1317-23
  11. Avril N, Menzel M, Dose J, et al. Glucose metabolism of breast cancer assessed by 18f-FDG PET: histologic and immunohistochemical tissue analysis. J Nucl Med 2001;42:9 -16
  12. Vesselle H, Schmidt RA, Pugsley JM, et al. Lung cancer proliferation correlates with [f-18]fluorodeoxyglucose uptake by positron emission tomography. Clin Cancer Res 2000;6:3837-44
  13. Tian M, Zhang H, Oriuchi N, et al. Comparison of 11c-choline PET and FDG PET for the differential diagnosis of malignant tumors. Eur J Nucl Med Mol Imaging 2004;31:1064 -72
  14. Ohtani T, Kurihara H, Ishiuchi S, et al. Brain tumour imaging with carbon-11 choline: comparison with FDG PET and gadolinium-enhanced MR imaging. Eur J Nucl Med 2001;28:1664 -70
  15. Hara T, Kosaka N, Shinoura N, et al. PET imaging of brain tumor with [methyl- 11c]choline. J Nucl Med 1997;38:842-47
  16. Utriainen M, Komu M, Vuorinen V, et al. Evaluation of brain tumor metabo- lism with [11c]choline PET and 1H-MRS. J Neurooncol 2003;62:329 -38
  17. Schiffer D, Bosone I, Dutto A, et al. The prognostic role of vessel productive changes and vessel density in oligodendroglioma. J Neurooncol 1999;44:99 -107
  18. Schiffer D, Dutto A, Cavalla P, et al. Prognostic factors in oligodendroglioma. Can J Neurol Sci 1997;24:313-19
  19. Cairncross JG, Ueki K, Zlatescu MC, et al. Specific genetic predictors of che- motherapeutic response and survival in patients with anaplastic oligodendro- gliomas. J Natl Cancer Inst 1998;90:1473-79
  20. Cairncross JG, Macdonald DR, Ramsay DA. Aggressive oligodendroglioma: a chemosensitive tumor. Neurosurgery 1992;31:78 -82
  21. Kapouleas I, Alavi A, Alves WM, et al. Registration of three-dimensional MR and PET images of the human brain without markers. Radiology 1991;181:731-39
  22. Narayanan TK, Said S, Mukherjee J, et al. A comparative study on the uptake and incorporation of radiolabeled methionine, choline and fluorodeoxyglu- cose in human astrocytoma. Mol Imaging Biol 2002;4:147-56
  23. Derlon JM, Petit-Taboue MC, Chapon F, et al. The in vivo metabolic pattern of low-grade brain gliomas: a positron emission tomographic study using 18f- fluorodeoxyglucose and 11c-l-methylmethionine. Neurosurgery 1997;40:276 - 87; discussion 287-78
  24. Bustany P, Chatel M, Derlon JM, et al. Brain tumor protein synthesis and histological grades: a study by positron emission tomography (PET) with c11- l-methionine. J Neurooncol 1986;3:397-404
  25. Plate KH, Breier G, Risau W. Molecular mechanisms of developmental and tumor angiogenesis. Brain Pathol 1994;4:207-18
  26. Plate KH, Risau W. Angiogenesis in malignant gliomas. Glia 1995;15:339 -47
  27. Theurillat JP, Hainfellner J, Maddalena A, et al. Early induction of angiogenetic signals in gliomas of gfap-v-src transgenic mice. Am J Pathol 1999;154:581-90
  28. Kracht LW, Friese M, Herholz K, et al. Methyl-[11c]-l-methionine uptake as measured by positron emission tomography correlates to microvessel density in patients with glioma. Eur J Nucl Med Mol Imaging 2003;30:868 -73
  29. Giammarile F, Cinotti LE, Jouvet A, et al. High and low grade oligodendrogli- omas (ODG): correlation of amino-acid and glucose uptakes using PET and histological classifications. J Neurooncol 2004;68:263-74
  30. Nariai T, Tanaka Y, Wakimoto H, et al. Usefulness of l-[methyl-11c] methio- nine-positron emission tomography as a biological monitoring tool in the treatment of glioma. J Neurosurg 2005;103:498 -507
  31. Hara T, Kondo T, Hara T, et al. Use of 18f-choline and 11c-choline as contrast agents in positron emission tomography imaging-guided stereotactic biopsy sampling of gliomas. J Neurosurg 2003;99:474 -79
  32. Miwa K, Shinoda J, Yano H, et al. Discrepancy between lesion distributions on methionine PET and MR images in patients with glioblastoma multiforme: Insight from a PET and MR fusion image study. J Neurol Neurosurg Psychiatry 2004;75:1457-62
  33. Levivier M, Massager N, Wikler D, et al. Use of stereotactic PET images in dosimetry planning of radiosurgery for brain tumors: clinical experience and proposed classification. J Nucl Med 2004;45:1146 -54
  34. Pirotte B, Goldman S, Dewitte O, et al. Integrated positron emission tomogra- phy and magnetic resonance imaging-guided resection of brain tumors: a re- port of 103 consecutive procedures. J Neurosurg 2006;104:238 -53